Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 161.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 163.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 30,263
  • Market Cap: £171.77m
  • RiskGrade: 352

Cello profit shrinks, ups divi

Date: Tuesday 16 Mar 2010

LONDON (ShareCast) - Shares in marketing services group Cello surged 9% as it said 2009 profit fell as clients cut spending but trading since the start of 2010 has been good.

Headline pre-tax profit fell to £5.1m for the year to 31 December 2009 from £7.3m the year before. Revenue from continuing operations dropped 8% to £126.7m.

Cello has recommended a final dividend of 0.80p per share, taking the total to 1.30p, up 4% from the year before.

Chief executive Mark Scott commented, "2009 was a demanding year. However, a combination of our very tight cost control and a better final six months for our Research and Consulting business gives us the confidence to increase our dividend."

He added, "We are leaner, more focused, with real strength in our core Research and Consulting activities. Long standing client relationships remain robust and gearing has been materially reduced. This puts us in a strong position to expand again."

Cello said it has renewed its banking facilities with The Royal Bank of Scotland until March 2013.





Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 161.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 163.50
52 Week Low 101.00
Volume 30,263
Shares Issued 106.69m
Market Cap £171.77m
RiskGrade 352

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average
Income
76.62% below the market average76.62% below the market average76.62% below the market average76.62% below the market average76.62% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Growth
30.41% below the market average30.41% below the market average30.41% below the market average30.41% below the market average30.41% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 07-Aug-2020

Time Volume / Share Price
16:30 618 @ 160.00p
16:03 11,000 @ 160.00p
16:01 8,003 @ 160.00p
15:21 310 @ 160.00p
15:19 8,000 @ 160.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page